OBJECTIVES: This pilot study investigated the accuracy of onsite immunoassay urinalysis of illicit drug use in 42 outpatients with co-occurring substance use disorders and serious mental illness. METHODS: Up to 40 urine samples were submitted by each participant as part of a larger study investigating the efficacy of contingency management in persons with co-occurring disorders. Each sample was analyzed for the presence of amphetamine, methamphetamine, cocaine, marijuana, and opiates or their metabolites using onsite qualitative immunoassays. One onsite urinalysis was randomly selected from each participant for confirmatory gas chromatography-mass spectrometry (GC-MS) analyses. RESULTS: Agreement between immunoassay and GC-MS was calculated. Agreement was high, with 98% agreement for amphetamine, methamphetamine, opiate, and marijuana. Agreement for cocaine was 93%. CONCLUSIONS: Results of this pilot study support the use of onsite immunoassay screening cups as an assessment and outcome measure in adults with serious mental illness. SCIENTIFIC SIGNIFICANCE: Data suggest that onsite urinalysis screenings may be a helpful assessment tool for measuring clinical and research outcomes.
OBJECTIVES: This pilot study investigated the accuracy of onsite immunoassay urinalysis of illicit drug use in 42 outpatients with co-occurring substance use disorders and serious mental illness. METHODS: Up to 40 urine samples were submitted by each participant as part of a larger study investigating the efficacy of contingency management in persons with co-occurring disorders. Each sample was analyzed for the presence of amphetamine, methamphetamine, cocaine, marijuana, and opiates or their metabolites using onsite qualitative immunoassays. One onsite urinalysis was randomly selected from each participant for confirmatory gas chromatography-mass spectrometry (GC-MS) analyses. RESULTS: Agreement between immunoassay and GC-MS was calculated. Agreement was high, with 98% agreement for amphetamine, methamphetamine, opiate, and marijuana. Agreement for cocaine was 93%. CONCLUSIONS: Results of this pilot study support the use of onsite immunoassay screening cups as an assessment and outcome measure in adults with serious mental illness. SCIENTIFIC SIGNIFICANCE: Data suggest that onsite urinalysis screenings may be a helpful assessment tool for measuring clinical and research outcomes.
Authors: Richard K Ries; Dennis G Dyck; Robert Short; Debra Srebnik; Mark Snowden; Katherine Anne Comtois Journal: Psychiatr Serv Date: 2002-06 Impact factor: 3.084
Authors: Christian Tomaszewski; Jeffrey Runge; Michael Gibbs; Stephen Colucciello; Marlow Price Journal: J Emerg Med Date: 2005-05 Impact factor: 1.484
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Jessica M Peirce; Nancy M Petry; John M Roll; Ken Kolodner; Joe Krasnansky; Patricia Q Stabile; Chanda Brown; Maxine L Stitzer Journal: Am J Drug Alcohol Abuse Date: 2009 Impact factor: 3.829
Authors: Michael G McDonell; Meredith C Graves; Imara I West; Richard K Ries; Dennis M Donovan; Kristin Bumgardner; Antoinette Krupski; Chris Dunn; Charles Maynard; David C Atkins; Peter Roy-Byrne Journal: J Addict Med Date: 2016 May-Jun Impact factor: 3.702
Authors: Jessica M Lowe; Michael G McDonell; Emily Leickly; Frank A Angelo; Roger Vilardaga; Sterling McPherson; Debra Srebnik; John Roll; Richard K Ries Journal: Alcohol Clin Exp Res Date: 2015-04-10 Impact factor: 3.455
Authors: Michael F Orr; Crystal Lederhos Smith; Myles Finlay; Samantha C Martin; Olivia Brooks; Oladunni A Oluwoye; Emily Leickly; Michael McDonell; Ekaterina Burduli; Celestina Barbosa-Leiker; Matt Layton; John M Roll; Sterling M McPherson Journal: Behav Pharmacol Date: 2018-08 Impact factor: 2.293